Get the content you want anytime you want.
REGISTER NOW | SIGN IN
6th International C diff Awareness Conference and Health EXPO

Select coverage from 6th International C diff Awareness Conference and Health EXPO is included below:

Bezlotoxumab More Effective in Patients with High Risk for <em>C Diff</em> Recurrence
Secondary analyses indicate that bezlotoxumab is more effective in reducing C diff recurrence in patients with pre-specified risk factors.
The Efficacy of Fecal Transplants for <i>C diff</i>
Sahil Khanna, MBBS, MS, discusses the efficacy of fecal transplants and new investigational candidates that are being evaluated in clinical trials.
Rapid Molecular Diagnostics for <i>C diff</i> and Sepsis
Maureen Spencer, RN, M.Ed., discusses how rapid molecular diagnostics are changing the treatment timeline for sepsis and Clostridium difficile (C diff).
The Contingent Valuation of <i>C Diff</i> Antibiotics
Glenn Tillotson, PhD discusses the development of new antibiotics and therapies for C diff during an era when antibiotic resistance is a serious global health threat.
Improving Hospital Disinfection to Prevent <i>C Diff</i>
Edmund A. Hooker, MD, DrPH, discussed the gaps in disinfection in the hospital and how hospital beds can be properly sanitized to prevent the spread healthcare-associatedted infections.
FEATURED
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.